4.7 Article

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

Related references

Note: Only part of the references are listed.
Article Biochemical Research Methods

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Da Wei Huang et al.

NATURE PROTOCOLS (2009)

Article Biochemistry & Molecular Biology

Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells

S. Dasgupta et al.

ONCOGENE (2009)

Article Multidisciplinary Sciences

AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

Daniel R. Rhodes et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Oncology

HER-2 and topoisomerase II as predictors of response to chemotherapy

Kathleen I. Pritchard et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Editorial Material Cell Biology

Breaking down EMT

Romain Levayer et al.

NATURE CELL BIOLOGY (2008)

Article Biochemical Research Methods

beadarray:: R classes and methods for Illumina bead-based data

Mark J. Dunning et al.

BIOINFORMATICS (2007)

Article Biochemistry & Molecular Biology

Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells

E. A. Burwell et al.

ONCOGENE (2007)

Article Cell Biology

TheEGF receptor family: spearheading a merger of signaling and therapeutics

Erez M. Bublil et al.

CURRENT OPINION IN CELL BIOLOGY (2007)

Review Immunology

The many faces of ITAMs

David M. Underhill et al.

TRENDS IN IMMUNOLOGY (2007)

Article Biotechnology & Applied Microbiology

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

Jason I. Herschkowitz et al.

GENOME BIOLOGY (2007)

Article Pharmacology & Pharmacy

R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation

Sylvia Braselmann et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Article Oncology

C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer

Elizabeth E. Evans et al.

MOLECULAR CANCER THERAPEUTICS (2006)

Article Biochemistry & Molecular Biology

Cellular ITAM-containing proteins are oncoproteins in nonhematopoietic cells

SM Grande et al.

ONCOGENE (2006)

Article Biochemistry & Molecular Biology

Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells

J Lu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Oncology

Modelling glandular epithelial cancers in three-dimensional cultures

J Debnath et al.

NATURE REVIEWS CANCER (2005)

Article Biotechnology & Applied Microbiology

Bioconductor: open software development for computational biology and bioinformatics

RC Gentleman et al.

GENOME BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Automated subcellular localization and quantification of protein expression in tissue microarrays

RL Camp et al.

NATURE MEDICINE (2002)

Article Multidisciplinary Sciences

Significance analysis of microarrays applied to the ionizing radiation response

VG Tusher et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells

PJP Coopman et al.

NATURE (2000)